Direxion Daily MSFT Bull 1.5X Shares

GraniteShares 2x Long MSFT Daily ETF

GraniteShares 1.5x Long META Daily ETF

GraniteShares 1.5x Long NVDA Daily ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares UltraPro QQQ

Direxion Daily S&P Biotech Bull 3X ETF

T-REX 2X Inverse Tesla Daily Target ETF

ProShares Ultra VIX Short-Term Futures

GraniteShares 1.5x Short NVDA Daily ETF

Direxion Daily TSLA Bull 1.5X Shares

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Guggenheim Solar ETF

ProShares UltraPro Short QQQ

Direxion Daily S&P Biotech Bear 3X ETF

Volatility Shares Trust 2x Ether ETF

United States Oil Fund

GraniteShares 1.5x Long Coinbase Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Regulus Therapeutics Inc. Common Stock

Jeffs' Brands Ltd Ordinary Shares

WW International Inc. Common Stock

Petros Pharmaceuticals Inc. Common Stock

LogicMark Inc. Common Stock

Sharps Technology Inc. Common Stock

Nvni Group Limited Ordinary Shares

New Gold Inc.

Urgent.ly Inc. Common Stock

Qorvo Inc. Common Stock

AgEagle Aerial Systems Inc. Common Stock

Autonomix Medical Inc. Common Stock

Snap Inc. Class A Common Stock

Super Micro Computer Inc. Common Stock

MicroAlgo Inc. Ordinary Shares

AtriCure Inc. Common Stock

Hillenbrand Inc Common Stock

CoStar Group Inc. Common Stock

Wearable Devices Ltd. Ordinary Share

First Solar Inc. Common Stock

Click here to get full coverage on HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation  Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq

Click here to get full coverage on Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results  Yahoo Finance

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance

Click here to get full coverage on Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - The Motley Fool

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript  The Motley Fool

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - The Motley Fool

Click here to get full coverage on Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus

Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target  GuruFocus

Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus

Click here to get full coverage on Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st

Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive  simplywall.st

Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st

Click here to get full coverage on Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan

Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method  Stock Titan

Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan

Click here to get full coverage on Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance

Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ...  Yahoo Finance

Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance

Click here to get full coverage on HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation  Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq

Click here to get full coverage on Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News - Stock Titan

Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News  Stock Titan

Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News - Stock Titan

Click here to get full coverage on Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus

Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025  GuruFocus

Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus

Click here to get full coverage on Breakthrough Genetic Testing Study Reveals 98.8% Accuracy Rate for Bionano's Cost-Cutting Technology - Stock Titan

Breakthrough Genetic Testing Study Reveals 98.8% Accuracy Rate for Bionano's Cost-Cutting Technology  Stock Titan

Breakthrough Genetic Testing Study Reveals 98.8% Accuracy Rate for Bionano's Cost-Cutting Technology - Stock Titan

Click here to get full coverage on Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus

Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement  GuruFocus

Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus

Click here to get full coverage on Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance

Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ...  Yahoo Finance

Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance

Click here to get full coverage on Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting | BNGO Stock News - Stock Titan

Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting | BNGO Stock News  Stock Titan

Bionano Genomics Issues Critical Stockholder Letter Ahead of Special Meeting | BNGO Stock News - Stock Titan

Click here to get full coverage on Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus

Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets  GuruFocus

Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus

Click here to get full coverage on Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Yahoo Finance

Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now  Yahoo Finance

Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Yahoo Finance

Click here to get full coverage on Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping - Stock Titan

Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping  Stock Titan

Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping - Stock Titan

Click here to get full coverage on Bionano Genomics (BNGO) Upgraded to Buy: Here's Why - Yahoo Finance

Bionano Genomics (BNGO) Upgraded to Buy: Here's Why  Yahoo Finance

Bionano Genomics (BNGO) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus

Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis  GuruFocus

Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus

Click here to get full coverage on Bionano Genomics Restructures Debt, Cuts Monthly Payments by 50% Through Mid-2025 to Boost Liquidity - Stock Titan

Bionano Genomics Restructures Debt, Cuts Monthly Payments by 50% Through Mid-2025 to Boost Liquidity  Stock Titan

Bionano Genomics Restructures Debt, Cuts Monthly Payments by 50% Through Mid-2025 to Boost Liquidity - Stock Titan

Click here to get full coverage on BNGO stock touches 52-week low at $3.73 amid market challenges - Investing.com

BNGO stock touches 52-week low at $3.73 amid market challenges  Investing.com

BNGO stock touches 52-week low at $3.73 amid market challenges - Investing.com

Click here to get full coverage on Bionano Genomics Raises $10M in Direct Offering, Secures Additional Warrant Funding Potential - Stock Titan

Bionano Genomics Raises $10M in Direct Offering, Secures Additional Warrant Funding Potential  Stock Titan

Bionano Genomics Raises $10M in Direct Offering, Secures Additional Warrant Funding Potential - Stock Titan

Click here to get full coverage on Where are the Opportunities in (BNGO) - news.stocktradersdaily.com

Where are the Opportunities in (BNGO)  news.stocktradersdaily.com

Where are the Opportunities in (BNGO) - news.stocktradersdaily.com

Click here to get full coverage on Bionano Genomics (BNGO) Highlights Optical Genome Mapping in Det - GuruFocus

Bionano Genomics (BNGO) Highlights Optical Genome Mapping in Det  GuruFocus

Bionano Genomics (BNGO) Highlights Optical Genome Mapping in Det - GuruFocus

Click here to get full coverage on Bionano Genomics stock slips on reverse stock split (BNGO) - Seeking Alpha

Bionano Genomics stock slips on reverse stock split (BNGO)  Seeking Alpha

Bionano Genomics stock slips on reverse stock split (BNGO) - Seeking Alpha

Click here to get full coverage on Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - AOL.com

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript  AOL.com

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - AOL.com

Click here to get full coverage on Bionano Genomics, Inc. Announces 1-for-60 Reverse Stock Split Effective January 24, 2025 - Nasdaq

Bionano Genomics, Inc. Announces 1-for-60 Reverse Stock Split Effective January 24, 2025  Nasdaq

Bionano Genomics, Inc. Announces 1-for-60 Reverse Stock Split Effective January 24, 2025 - Nasdaq

Click here to get full coverage on Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS) and BioNano Genomics (BNGO) - The Globe and Mail

Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS) and BioNano Genomics (BNGO)  The Globe and Mail

Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS) and BioNano Genomics (BNGO) - The Globe and Mail

Click here to get full coverage on BioNano Genomics Announces $10 Million Direct Offering - Yahoo Finance

BioNano Genomics Announces $10 Million Direct Offering  Yahoo Finance

BioNano Genomics Announces $10 Million Direct Offering - Yahoo Finance

Click here to get full coverage on Bionano Genomics ends sales agreement with Cowen - Investing.com

Bionano Genomics ends sales agreement with Cowen  Investing.com

Bionano Genomics ends sales agreement with Cowen - Investing.com

Click here to get full coverage on Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline - Investing.com

Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline  Investing.com

Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline - Investing.com

Click here to get full coverage on Bionano Genomics shareholders approve stock issuance and reverse split - Investing.com

Bionano Genomics shareholders approve stock issuance and reverse split  Investing.com

Bionano Genomics shareholders approve stock issuance and reverse split - Investing.com

Click here to get full coverage on Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Stock Titan

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules  Stock Titan

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Stock Titan

Click here to get full coverage on Bionano Genomics stock hits 52-week low at $0.17 amid market challenges - MSN

Bionano Genomics stock hits 52-week low at $0.17 amid market challenges  MSN

Bionano Genomics stock hits 52-week low at $0.17 amid market challenges - MSN

Click here to get full coverage on Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus

Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates  GuruFocus

Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus

Click here to get full coverage on Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview - TradingView

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview  TradingView

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview - TradingView

Click here to get full coverage on Bionano Genomics initiated with a Buy at H.C. Wainwright - TipRanks

Bionano Genomics initiated with a Buy at H.C. Wainwright  TipRanks

Bionano Genomics initiated with a Buy at H.C. Wainwright - TipRanks

Click here to get full coverage on BioNano Genomics Executes Significant Reverse Stock Split - TipRanks

BioNano Genomics Executes Significant Reverse Stock Split  TipRanks

BioNano Genomics Executes Significant Reverse Stock Split - TipRanks

Click here to get full coverage on HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com

HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target  marketscreener.com

HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com

Click here to get full coverage on BioNano Genomics Restructures Debt to Boost Liquidity - TipRanks

BioNano Genomics Restructures Debt to Boost Liquidity  TipRanks

BioNano Genomics Restructures Debt to Boost Liquidity - TipRanks

Click here to get full coverage on Bionano Genomics faces Nasdaq delisting over share price - Investing.com

Bionano Genomics faces Nasdaq delisting over share price  Investing.com

Bionano Genomics faces Nasdaq delisting over share price - Investing.com

Click here to get full coverage on What's Next: Bionano Genomics's Earnings Preview - Benzinga

What's Next: Bionano Genomics's Earnings Preview  Benzinga

What's Next: Bionano Genomics's Earnings Preview - Benzinga

Click here to get full coverage on Bionano Genomics Sees Growth in OGM Adoption - TipRanks

Bionano Genomics Sees Growth in OGM Adoption  TipRanks

Bionano Genomics Sees Growth in OGM Adoption - TipRanks

Click here to get full coverage on Bionano Genomics Reports 2024 Financial Results - TipRanks

Bionano Genomics Reports 2024 Financial Results  TipRanks

Bionano Genomics Reports 2024 Financial Results - TipRanks

Click here to get full coverage on BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com UK

BNGO stock touches 52-week low at $3.15 amid market challenges  Investing.com UK

BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com UK

Click here to get full coverage on Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks

Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts  TipRanks

Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks

Click here to get full coverage on Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com

Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop  Investing.com

Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com

Click here to get full coverage on BioNano Genomics Ends Sales Agreement with Cowen - TipRanks

BioNano Genomics Ends Sales Agreement with Cowen  TipRanks

BioNano Genomics Ends Sales Agreement with Cowen - TipRanks

Click here to get full coverage on Bionano Announces Effective Date of Reverse Stock Split - The Manila Times

Bionano Announces Effective Date of Reverse Stock Split  The Manila Times

Bionano Announces Effective Date of Reverse Stock Split - The Manila Times

Click here to get full coverage on Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis - GlobeNewswire

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis  GlobeNewswire

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis - GlobeNewswire

Click here to get full coverage on Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2024 Results - TradingView

Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2024 Results  TradingView

Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2024 Results - TradingView

Click here to get full coverage on 3 Stocks That Are Poised to Generate Outsized Returns - Yahoo Finance

3 Stocks That Are Poised to Generate Outsized Returns  Yahoo Finance

3 Stocks That Are Poised to Generate Outsized Returns - Yahoo Finance

Click here to get full coverage on Bionano Genomics: A Noble Cause But A Bad Investment (BNGO) - Seeking Alpha

Bionano Genomics: A Noble Cause But A Bad Investment (BNGO)  Seeking Alpha

Bionano Genomics: A Noble Cause But A Bad Investment (BNGO) - Seeking Alpha

Click here to get full coverage on Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - The Manila Times

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease  The Manila Times

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - The Manila Times

Bionano Genomics Inc (BNGO)

Price Chart

Key Statistics

Technicals

About BNGO

Latest News

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - The Motley Fool

Advanced Charts

Top Gainers

Top Losers